Utilizing its subsidiaries such as Suining Yinfa DAR Industrial Co. Ltd, China Health Resource, Inc. (OTCBB: CHRI) produces, processes, and commercializes the widely-used traditional Chinese herb, Dahurian Angelica Root. China Health is based out of the Sichuan province and represents more than 70% of the country’s DAR total output.
The root is considered an integral ingredient in traditional Chinese medicine, and is used to treat pain, high blood pressure, cancer and other ailments. The root is also known to reduce itching and has an energizing aroma thought to awaken the brain.
China Health has signed a letter of intent with Sichuan Zhefeng Medicine Co. to enhance the achievements of the company’s industrial chain plan. According to the plan, Zhefeng will serve as the production base for China Health’s DAR products. From here China Health plans to expand the growing area of the herbal root, develop a Good Manufacture Practice certified process factory, and establish a Good Supplying Practice sales platform.
Through this growth strategy, China Health intends on becoming a key competitive player in the industry, dominating market share and increasing the value of DAR.
Let us hear your thoughts: China Health Resource, Inc. Message Board